P33 ING1 Antibody Conjugated to HRP

<strong>p33 ING1 Antibody Conjugated to HRP</strong>_x000D_ <strong>Catalog number:</strong> B2015788_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 ¬∞C_x000D_ <strong>Keywords:</strong> p33 ING1 Antibody, HRP_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Campos EI, Xiao H, Li G. Generation of a polyclonal antibody specifically against the p33(ING1b) tumor suppressor J Immunoassay Immunochem. 2004;25(1):71-80._x000D_ 2: Suzuki K, Boland D, Gong W, Riabowol K. Domain recognition of the ING1 tumor suppressor by a panel of monoclonal antibodies Hybridoma (Larchmt). 2011 Jun;30(3):239-45._x000D_ 3: Gong W, Russell M, Suzuki K, Riabowol K. Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression Mol Cell Biol. 2006 Apr;26(8):2947-54._x000D_ 4: Ahmed IA, Kelly SB, Anderson JJ, Angus B, Challen C, Lunec J. The predictive value of p53 and p33(ING1b) in patients with Dukes'C colorectal cancer Colorectal Dis. 2008 May;10(4):344-51._x000D_ 5: Nouman GS, Angus B, Lunec J, Crosier S, Lodge A, Anderson JJ. Comparative assessment expression of the inhibitor of growth 1 gene (ING1) in normal and neoplastic tissues Hybrid Hybridomics. 2002 Feb;21(1):1-10._x000D_ 6: Saito A, Furukawa T, Fukushige S, Koyama S, Hoshi M, Hayashi Y, Horii A. p24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of p33/ING1 J Hum Genet. 2000;45(3):177-81._x000D_ 7: Cheung KJ Jr, Li G. p33(ING1) enhances UVB-induced apoptosis in melanoma cells Exp Cell Res. 2002 Oct 1;279(2):291-8._x000D_ 8: Ohgi T, Masaki T, Nakai S, Morishita A, Yukimasa S, Nagai M, Miyauchi Y, Funaki T, Kurokohchi K, Watanabe S, Kuriyama S. Expression of p33(ING1) in hepatocellular carcinoma: relationships to tumour differentiation and cyclin E kinase activity Scand J Gastroenterol. 2002 Dec;37(12):1440-8._x000D_ 9: Takahashi M, Seki N, Ozaki T, Kato M, Kuno T, Nakagawa T, Watanabe K, Miyazaki K, Ohira M, Hayashi S, Hosoda M, Tokita H, Mizuguchi H, Hayakawa T, Todo S, Nakagawara A. Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG Cancer Res. 2002 Apr 15;62(8):2203-9._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/11835353">10: Ito K, Kinjo K, Nakazato T, Ikeda Y, Kizaki M. Expression and sequence analyses of p33(ING1) gene in myeloid leukemia Am J Hematol. 2002 Feb;69(2):141-3. </a>_x000D_ _x000D_ <strong>Products Related to p33 ING1 Antibody Conjugated to HRP can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>